Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
Research grant on health disparities in Latin America for NCDs, focusing on clinical epidemiology and policy evaluation, requiring collaboration with Latin American institutions.
Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Typical R01 awards range from $250,000–$500,000/year in direct costs.
Summary: Supports collaborative, multidisciplinary research on health and healthcare disparities in non-communicable and chronic diseases in Latin America and among U.S. Hispanics/Latinos; requires meaningful partnership with Latin American institutions.
Key Information: Clinical trials are not allowed. At least one PI/MPI must be from a Latin American institution; majority of research and budget (approx. 70%) must be conducted in Latin America.
Description
This NIH funding opportunity supports innovative, collaborative, and interdisciplinary research projects focused on understanding and addressing health and healthcare disparities related to non-communicable and chronic diseases (NCDs) in Latin America and among U.S. Hispanics/Latinos. The program emphasizes clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements, with the goal of improving health outcomes and reducing disparities across the hemisphere.
Projects must be conducted by multidisciplinary teams that include at least one principal investigator (PI) or multiple principal investigator (MPI) from a Latin American institution. The majority of research activities and budget (approximately 70%) should be allocated to Latin America-based institutions, with the remainder to U.S.-based partners.
Clinical trials are not permitted under this opportunity.
